CN
|
EN
Home
Introduction to the 2023 CBIIC
Main Conference
Previous Speakers
News
Organizations
Service
Transportation & Accommodation
Guidance
Contact us
Previous Review
Home
About CBIIC
Agenda
Previous Speakers
News
Expert
Organizations
Service
Transportation & Accommodation
Guidance
Contact us
Previous Review
Business Matching Service
Register
Roadshow Application
Onsite Participant Registration
CN
EN
Oversea Projects Roadshow
Agendas
14:00 - 17:00
境外项目路演专场
Oversea Projects Roadshow
Moderator
裴海岚 , 澳大利亚维多利亚州政府高级投资代表
Helen PEI , Senior Investment Manager, State Government of Victoria, Australia
14:00 - 14:20
主旨报告
Keynote Speeches
瑞士巴塞尔大区,落户欧洲优选之地
Basel Area, A Great Location for Your Investment in Europe
邹晓平 瑞士巴塞尔大区经济和创新促进局中国首席代表
ZOU Xiaoping , Chief Representative China, Basel Area Business & Innovation
14:20 - 14:40
项目1
Project 1
新一代创新型基因编辑公司
A Next Generation Innovative in Vivo Gene Editing Company
竺添 GenEditBio首席执行官
ZHU Tian , CEO, GenEditBio
14:40 - 15:00
项目2
Project 2
为希望的微笑——全球第一个治疗自闭症的项目
A Smile of Hope - The World’s First Treatment for Autism
Joan Fallon Curemark首席执行官
Joan Fallon , CEO, Curemark
15:00 - 15:20
项目3
Project 3
将TDP-43抑制剂开发成用于治疗渐冻症和阿尔兹海默症的原创靶向新药
Development of TDP-43 Inhibitors for the Treatment of ALS, Alzheimer's Disease and Other Neurodegenerative Disorders
张承亮 Alteron Therapeutics Inc首席执行官
ZHANG Chengliang , CEO, Alteron Therapeutics Inc
15:20 - 15:40
项目4
Project 4
应用的新型 Aflibercept-CPP™滴眼液治疗糖尿病视网膜病变和视网膜静脉阻塞患者
Innovative Breakthrough in Ophthalmology Patient Care: Novel Aflibercept-CPP Eye-Drop Treatment in Patients with DR and RVO
李德晃 奥朗生物医药有限公司首席执行官
Benjamin TK Lee , CEO, Alephoson Biopharmaceuticals
15:40 - 16:00
项目5
Project 5
基于免疫代谢策略来研发治疗各类慢性疾病新药物
Pioneering New Medicines for The Treatment of Autoimmune Diseases by Targeting Immuno-METAbolism
汪子俊 默达生物(香港)科技有限公司公司事务负责人
Alex WANG , Chief of Staff, Meta Pharmaceuticals(HK) Inc.
16:00 - 16:20
项目6
Project 6
临床实验室的全球合作伙伴
Your Global Partner for Clinical Trial Laboratories
Maarten Brusse Cerba Research亚太区总经理
Maarten Brusse , General Manager APAC,Cerba Research
16:20 - 16:40
项目7
Project 7
基于靶向神经的调节技术
Wearable and Treatable Medical Devices
纪五丰 越凡智能科技有限公司董事长
Peter JI , Chairman, WAT Medical Technology LLC.
16:40 - 17:00
项目8
Project 8
欧洲领先的蛋白降解技术:突破肿瘤、自身免疫和神经系统疾病治疗的新前景
Using Targeted Protein Degradation (TPD) Technology to Treat Cancer and Autoimmune Diseases
Tom Shepherd Captor Therapeutics首席执行官
Tom Shepherd , CEO, Captor Therapeutics